Cardiome Pharma (CRME) Up Despite Quarterly Loss

Cardiome Pharma Corp.

shares gained 1.8% to $4.98 on a quarterly net loss of $1.2 million (loss per share of $0.06), compared to a net loss of $3.9 million (loss per share of $0.23) for the prior-year quarter. Revenue for the three months ended March 31, 2016 was $7.1 million compared to revenue of $5.5 million for the prior-year quarter. Share volume was 19,000, compared to an all-day average of 40,000